Title |
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
|
---|---|
Published by |
John Wiley & Sons, Ltd, April 2013
|
DOI | 10.1002/14651858.cd009008.pub2 |
Pubmed ID | |
Authors |
Hemmingsen, Bianca, Schroll, Jeppe B, Lund, Søren S, Wetterslev, Jørn, Gluud, Christian, Vaag, Allan, Sonne, David Peick, Lundstrøm, Lars H, Almdal, Thomas P |
Abstract |
Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. Whether sulphonylureas show better, equal or worse therapeutic effects in comparison with other antidiabetic interventions for patients with T2DM remains controversial. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 11% |
Ecuador | 1 | 11% |
Canada | 1 | 11% |
Unknown | 6 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 67% |
Science communicators (journalists, bloggers, editors) | 3 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
Denmark | 1 | <1% |
Ireland | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 111 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 18 | 16% |
Student > Master | 15 | 13% |
Student > Postgraduate | 13 | 11% |
Student > Ph. D. Student | 10 | 9% |
Student > Bachelor | 9 | 8% |
Other | 25 | 22% |
Unknown | 25 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 61 | 53% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
Nursing and Health Professions | 4 | 3% |
Economics, Econometrics and Finance | 3 | 3% |
Social Sciences | 3 | 3% |
Other | 7 | 6% |
Unknown | 31 | 27% |